IL120469A0 - 1, 25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives their preparation and pharmaceutical compositions containing them - Google Patents

1, 25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL120469A0
IL120469A0 IL12046997A IL12046997A IL120469A0 IL 120469 A0 IL120469 A0 IL 120469A0 IL 12046997 A IL12046997 A IL 12046997A IL 12046997 A IL12046997 A IL 12046997A IL 120469 A0 IL120469 A0 IL 120469A0
Authority
IL
Israel
Prior art keywords
trisdehydro
dihydroxy
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL12046997A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL120469A0 publication Critical patent/IL120469A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12046997A 1996-03-21 1997-03-17 1, 25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives their preparation and pharmaceutical compositions containing them IL120469A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
IL120469A0 true IL120469A0 (en) 1997-07-13

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12046997A IL120469A0 (en) 1996-03-21 1997-03-17 1, 25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
EP (1) EP0796843B1 (xx)
JP (1) JP2801587B2 (xx)
KR (1) KR100240541B1 (xx)
CN (1) CN1110477C (xx)
AR (1) AR006315A1 (xx)
AT (1) ATE240941T1 (xx)
AU (1) AU708679B2 (xx)
BR (1) BR9701404A (xx)
CA (1) CA2199893C (xx)
CO (1) CO4820396A1 (xx)
CZ (1) CZ85897A3 (xx)
DE (1) DE69722064T2 (xx)
DK (1) DK0796843T3 (xx)
ES (1) ES2198512T3 (xx)
HR (1) HRP970162A2 (xx)
HU (1) HUP9700609A3 (xx)
ID (1) ID16285A (xx)
IL (1) IL120469A0 (xx)
MA (1) MA26423A1 (xx)
MX (1) MX9702139A (xx)
NO (1) NO971217L (xx)
NZ (1) NZ314424A (xx)
PE (1) PE42998A1 (xx)
PL (1) PL319070A1 (xx)
PT (1) PT796843E (xx)
SG (1) SG70589A1 (xx)
TR (1) TR199700219A3 (xx)
TW (1) TW444001B (xx)
YU (1) YU10397A (xx)
ZA (1) ZA972302B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
ATE99942T1 (de) * 1989-05-18 1994-01-15 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
EP0796843B1 (en) 2003-05-21
CN1110477C (zh) 2003-06-04
HUP9700609A3 (en) 1999-03-01
HRP970162A2 (en) 1998-04-30
CN1172793A (zh) 1998-02-11
TR199700219A2 (xx) 1997-10-21
TR199700219A3 (tr) 1997-10-21
CZ85897A3 (cs) 1998-04-15
ATE240941T1 (de) 2003-06-15
AU708679B2 (en) 1999-08-12
ES2198512T3 (es) 2004-02-01
ID16285A (id) 1997-09-18
PT796843E (pt) 2003-09-30
AR006315A1 (es) 1999-08-25
AU1513597A (en) 1997-09-25
EP0796843A2 (en) 1997-09-24
CA2199893A1 (en) 1997-09-21
PL319070A1 (en) 1997-09-29
DK0796843T3 (da) 2003-09-15
KR970065495A (ko) 1997-10-13
YU10397A (sh) 1999-07-28
MA26423A1 (fr) 2004-12-20
JP2801587B2 (ja) 1998-09-21
HUP9700609A2 (hu) 1998-07-28
NO971217D0 (no) 1997-03-17
PE42998A1 (es) 1998-08-11
CO4820396A1 (es) 1999-07-28
JPH107651A (ja) 1998-01-13
HU9700609D0 (en) 1997-05-28
BR9701404A (pt) 1998-11-03
TW444001B (en) 2001-07-01
DE69722064T2 (de) 2004-04-08
ZA972302B (en) 1997-09-22
EP0796843A3 (en) 1999-04-14
DE69722064D1 (de) 2003-06-26
CA2199893C (en) 2008-02-05
NO971217L (no) 1997-09-22
MX9702139A (es) 1998-04-30
SG70589A1 (en) 2000-02-22
NZ314424A (en) 1998-07-28
KR100240541B1 (ko) 2000-01-15

Similar Documents

Publication Publication Date Title
NZ304901A (en) Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same
IL109316A0 (en) 1, 5-benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
IL111314A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
HUP9700709A3 (en) 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL109234A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL108859A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
IL111294A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL110980A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL112097A0 (en) Indoline derivatives, their preparation and pharmaceutical compositions containing them
IL108703A0 (en) Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
IL110366A0 (en) 1,5-Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
IL117806A (en) 1,3-dihydro-2H-imidazol-2-one derivatives their preparation and pharmaceutical compositions containing them
IL105774A0 (en) Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them